Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication

This prospective study was to assess the efficacy of nonbismuth containing quadruple therapy as first-line H. pylori treatment and to determine the clinical factors influencing patient outcome. We enrolled 200 H. pylori-infected naïve patients. They were prescribed either a 7-day nonbismuth containi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Res Int
Autors principals: Tai, Wei-Chen, Liang, Chih-Ming, Lee, Chen-Hsiang, Chiu, Chien-Hua, Hu, Ming-Luen, Lu, Lung-Sheng, Kuo, Yuan-Hung, Kuo, Chung-Mou, Yen, Yi-Hao, Kuo, Chung-Huang, Chiou, Shue-Shian, Wu, Keng-Liang, Chiu, Yi-Chun, Hu, Tsung-Hui, Chuah, Seng-Kee
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2015
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4452293/
https://ncbi.nlm.nih.gov/pubmed/26090428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/623732
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars